IXHL
NASDAQ
AU
Incannex Healthcare Inc. - Common Stock
$2.90
▼ $-0.06
(-2.03%)
Vol 388K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$123.9M
ROE
-144.2%
Margin
-18137.8%
D/E
0.00
Beta
2.70
52W
$0–$2
Price Chart
Earnings
Beat rate: 75.0%
Next Report
May 13, 2026
EPS Estimate: $-0.94
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2026 | $-0.94 | — | — |
| Dec 2025 | $-0.94 | $-0.60 | +$0.34 |
| Sep 2025 | $-0.94 | $-0.60 | +$0.34 |
| Jun 2025 | $-89.29 | $-15.30 | +$73.99 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | $74K | $12K | — | — | — | — |
| Net Income | -$5.4M | -$5.9M | -$4.0M | — | -$6.4M | -$6.5M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -614.6% | -289.3% | -289.3% | -614.6% | -144.2% | -144.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -54517.4% | -18137.8% | -18137.8% | -18137.8% | -18137.8% | -18137.8% |
| Gross Margin | — | 115.3% | 115.3% | 115.3% | 115.3% | 115.3% |
| D/E Ratio | 0.00 | 18.87 | 18.87 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.86 | 2.12 | 2.12 | 2.86 | 47.51 | 47.51 |
Key Ratios
ROA (TTM)
-119.4%
P/S (TTM)
1264.78
P/B
4.2
EPS (TTM)
$-0.74
Rev Growth 3Y
-52.2%
52W High
$2.25
52W Low
$0.08
$0.08
52-Week Range
$2.25
Financial Health
Free Cash Flow
-$4.6M
Net Debt
-$68.7M
Cash
$68.9M
Total Debt
$163K
As of Dec 31, 2025
How does IXHL compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
IXHL valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
1264.8
▲
25451%
above
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
4.2
▲
97%
above
peers
(2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
IXHL profitability vs Pharmaceuticals peers
ROE
-144.2%
▼
166%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
-18137.8%
▼
38190%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
115.3%
▲
69%
above
peers
(68.3%)
vs Peers
vs Industry
Below avg
ROA
-119.4%
▼
219%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
IXHL financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
47.5
▲
1314%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.7
▲
187%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
IXHL fundamentals radar
IXHL
Peer median
Industry
IXHL profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IXHL vs peers: key metrics
Top Holders
Top 5: 2.21%Mirae Asset Global ETFs Hol…
0.77%
$293K
Arete Wealth Advisors, LLC
0.62%
$236K
Jane Street Group, LLC
0.42%
$159K
Virtu Financial LLC
0.21%
$80K
AdvisorShares Investments, …
0.19%
$71K
As of Dec 31, 2025
Latest News
No related news yet